Shire, Teva Settle Contract Spat Over Adderall Supplies

Law360, New York (December 2, 2009, 2:11 PM EST) -- Shire PLC said on Wednesday that it had reached a settlement with Teva Pharmaceuticals USA Inc., which had accused the British drug manufacturer of breaching a contract to supply the generics maker with supplies of Adderall XR.

Under the terms of the settlement, “no consideration was exchanged,” Shire said in a statement.

In its suit Teva claimed that Shire had breached a contract between the two companies requiring Shire to provide Teva with an authorized generic version of Adderall, a blockbuster drug used to treat attention...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.